Barbara Krebs-Pohl
Fortune : - $ au 31/03/2026
Fortune : - $ au 31/03/2026
Dr. Barbara Krebs-Pohl is an Independent Director at Inventiva SA. She is on the Board of Directors at Inventiva SA and Human Immunology Biosciences, Inc. Dr. Krebs-Pohl was previously employed as an Independent Director by CASI Pharmaceuticals, Inc. and a Chief Business Officer by MorphoSys AG.
She also served on the board at HIBio, Inc. She received her graduate degree from Universität zu Köln and a doctorate degree from The Johannes Gutenberg University of Mainz.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/04/2026 | 0 ( -.--% ) | - $ | 31/03/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| INVENTIVA | Directeur/Membre du Conseil | 30/06/2026 |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing therapies for immune-mediated diseases | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 31/05/2026 |
HIBio, Inc.
HIBio, Inc. BiotechnologyHealth Technology Develops transformative therapies | Directeur/Membre du Conseil | - |
| MORPHOSYS AG | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johannes Gutenberg University of Mainz
The Johannes Gutenberg University of Mainz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inventiva SA
Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
HIBio, Inc.
HIBio, Inc. BiotechnologyHealth Technology Develops transformative therapies | Health Technology |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing therapies for immune-mediated diseases | Health Technology |
CASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics and pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national